Navigation Links
Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
Date:8/19/2009

LONDON, Aug. 19 /PRNewswire/ -- Increasing knowledge related to the pathology of diabetes will support the introduction of improved drugs to treat the disease. As healthcare moves towards the ideal of preventive medicine, there are a few companies conducting research on diabetes vaccines. If they succeed, the entire market landscape is bound to undergo instant change.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.pharma.frost.com), Global Diabetes Market, finds that the market earned revenues of $27.00 billion in 2008 and estimates this to reach $44.70 billion in 2015.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brief brochure will be sent to you by e-mail.

"Improved therapies and innovative drug delivery techniques are anticipated to revolutionise the global diabetes market by 2015," notes Frost & Sullivan Programme Leader Sylvia Miriyam Findlay. "As healthcare moves towards preventive medicine, the search for a cure for diabetes looks promising."

The emergence of newer classes of drug
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Emergence of Cancer Vaccines Will Be the Key Factor Driving the Pancreatic Cancer Drug Market to More Than Double by 2016
2. Kaiser Permanente Study Shows Newer, Stronger Evidence That Caffeine During Pregnancy Increases Miscarriage Risk
3. ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes
4. First Pediatric Patient Treated With Aptocine(TM), a Novel Light-Activated Drug, in Neurofibromatosis Study
5. Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium
6. Omnio Healer Selects Eden Biodesign for cGMP Production of its Candidate Wound Healing and Anti-Infection Treatments
7. Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure
8. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
9. Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab
10. AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
11. Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... IL (PRWEB) January 15, 2014 Look ... find hard-working items for the lab, from fluid handling ... Guaranteed-in-Stock (GIS)—ready to ship when you order. , ... Peristaltic Pumps , from the L/S® model for precise ...
(Date:1/15/2014)... OXFORD, England and SAN JOSE, California ... an international biotechnology company developing antibody-drug conjugates for cancer, today ... its Board of Directors. Dr Reynolds has over 20 years, ... Chief Medical Officer at Seattle Genetics. "I am ...
(Date:1/15/2014)... This webinar will focus on EMA and ... in biosimilars. , Regulatory frameworks are evolving many countries ... the complex nature of biopharmaceuticals makes the demonstration of ... challenging. Based on the specific aspects of biosimilar drug ...
(Date:1/15/2014)... More than 5 million Americans are ... 3 seniors will die with Alzheimer’s or another dementia, ... have shocked many Americans into looking for ways to ... tragic age-related cognitive disorders. Jonathan Weisman, president of Biohack ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2
... Technologies , a high-technology spin-off of the University of ... during the biggest blackout the nation has ever seen. ... Near-simultaneous events were recorded in New York and Michigan ... across the northeastern United States, with the I-Grid recording ...
... Wisconsin companies recently won CIO magazines CIO ... resourcefulness regarding the use of information technology(IT) within their ... Menasha Corp. each won the award, announced in the ... Manpower CIOs are on the cover of the magazine. ...
... a two-year grant from the state Department of Commerce ... which for years trailed their counterparts in Madison in ... up. Thats good news for Milwaukee - which means ... wants to transform itself from an old-line manufacturing burg ...
Cached Biology Technology:Local Company Records Blackout with Web-Based Monitoring System 2Local Company Records Blackout with Web-Based Monitoring System 3Five Wisconsin Non-Tech Companies Win IT Awards 2Five Wisconsin Non-Tech Companies Win IT Awards 3Five Wisconsin Non-Tech Companies Win IT Awards 4Milwaukee research institutions step up the pace for technology transfer 2
(Date:4/23/2014)... of dementia and affects some 400,000 people in Spain ... One of the reasons for this is the lack ... in nerve transmissions and the loss of memory in ... Institute of Neuroscience at the Universitat Autnoma de Barcelona ... and were able to develop a gene therapy which ...
(Date:4/23/2014)... of social relationships they may be friends, kin, ... From a cognitive perspective, understanding one,s own relationships to ... ("knowing who is nice or not"). Yet, understanding also ... the stage for "political" maneuvers ("knowing who might support ... in the scientific journal Nature Communications . ...
(Date:4/23/2014)... London (April 23, 2014). "I think one can argue that ... well as doing everything else that we canthen we can ... Wigley, one of the world,s foremost climate researchers, in the ... published by SAGE. Refusing to take significant action on climate ... be needed to address the problem, Wigley explains in an ...
Breaking Biology News(10 mins):Loss of memory in Alzheimer's mice models reversed through gene therapy 2Ravens understand the relations among others 2Is nuclear power the only way to avoid geoengineering? 2
... different from what a runner might take on a ... to make life more comfortable for cattle. A ... a pedometer are a few of the tools K-State ... two routine procedures, castration and dehorning. Hans Coetzee, ...
... including nursery and greenhouse producers, landscape services firms, ... during the past two decades, becoming an increasingly ... the Green Industry generated 1.96 million jobs and ... U.S. nursery and greenhouse crops reached $16.9 billion. ...
... the twelfth release in a series of erect-growing, ... Watson) cultivars developed by the University of Arkansas. ... of the Department of Horticulture at the University ... issue of the American Society of Horticultural Science,s ...
Cached Biology News:Veterinarians developing model to help producers, vets make cattle more comfortable 2Veterinarians developing model to help producers, vets make cattle more comfortable 3Results of national nursery survey unveiled 2
... clone d1-174 GenBank Accession Number : ... N-terminal tagged fusion protein corresponding to full ... Tris-glycine, pH 7.4, 0.15M NaCl, 0.05% sodium ... 30% Quality Assurance: routinely evaluated by immunoblot ...
...
X-Gal, 1 g. 5-Bromo-4-chloro-3-indolyl-b-d-galactoside.Histochemical substrate for b-galactosidase, used in blue/white screening.Store at -20 C. Protect from moisture. Category: Nucleotides & Enzymes...
Conjugation services for Antibodies, Proteins, Oligos, Peptides, Beads, bioconjugation, antibody-oligonucleotide, LNA peptide, LNA protein, LNA antibody, HRP, Alkaline phosphatase, phycoerythrin, FIT...
Biology Products: